The fastest-growing and largest of the 26 sized Medical Devices markets worldwide, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Anesthesia Monitoring Devices | $2.6 Bn | $8.6 Bn | 12.5% | 821 |
| 2 | Aesthetic Lasers and Energy Devices | $1.6 Bn | $5.1 Bn | 12.1% | 134 |
| 3 | Insulin Patch Pumps | $890 Mn | $2.8 Bn | 12% | 21 |
| 4 | Dental Caries Detectors | $370 Mn | $1.1 Bn | 11.8% | 206 |
| 5 | Anesthesia & Respiratory Devices | $28.7 Bn | $71.1 Bn | 9.5% | 1,235 |
| 6 | Air Ambulance Life Support Solutions | $4.5 Bn | $10.7 Bn | 9.1% | 30 |
| 7 | Anti-Snoring Devices | $1.3 Bn | $2.9 Bn | 8.8% | 262 |
| 8 | Advanced Bipolar Direct Energy Devices | $3.1 Bn | $7.1 Bn | 8.7% | 687 |
| 9 | Acute Care Needleless Connectors | $490 Mn | $1 Bn | 7.5% | 3 |
| 10 | Disposable Surgical Devices | $9 Bn | $18.3 Bn | 7.3% | 15,939 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Diabetes Care Devices | $42.6 Bn | $75.6 Bn | 5.9% | 941 |
| 2 | Anesthesia & Respiratory Devices | $28.7 Bn | $71.1 Bn | 9.5% | 1,235 |
| 3 | Rehabilitation Equipments | $20 Bn | $36.2 Bn | 6.1% | 2,705 |
| 4 | Defibrillator | $17.7 Bn | $31.5 Bn | 5.9% | 528 |
| 5 | Insulin Delivery Devices | $15.9 Bn | $29.8 Bn | 6.5% | 354 |
| 6 | Angiography Devices | $12.5 Bn | $22.9 Bn | 6.3% | 1,764 |
| 7 | Dental Diagnostic and Surgical Equipments | $12 Bn | $23.8 Bn | 7.1% | 4,828 |
| 8 | Direct Energy Medical Devices | $11 Bn | $18 Bn | 5% | 1,861 |
| 9 | Disposable Surgical Devices | $9 Bn | $18.3 Bn | 7.3% | 15,939 |
| 10 | Audiology Devices | $7.8 Bn | $14.6 Bn | 6.4% | 355 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.
Anesthesia Monitoring Devices grows fastest, at 12.5% a year from 2023 to 2033, ahead of Aesthetic Lasers and Energy Devices (12.1%).
Diabetes Care Devices is the largest, worth about $42.6 Bn in 2023 and $75.6 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.